BioNTech Co-Founders to Transition Roles as They Launch New Company
BioNTech Chief Executive Officer and Co-Founder Ugur Sahin and Co-Founder Özlem Türeci plan to transition out of their current roles by the end of 2026 to lead a new biotechnology company focused on next-generation mRNA technologies. BioNTech said the new venture will operate independently, with its own resources, operations, and funding options, while the company’s supervisory board has begun a search for successors as part of the leadership transition…










